HMG-CoA Reductase Inhibitor [EPC]

370949 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN ATORVASTATIN CALCIUM EZETIMIBE AND SIMVASTATIN ROSUVASTATIN PITAVASTATIN MAGNESIUM

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 20899
1 NAUSEA 19290
2 DRUG INEFFECTIVE 18919
3 DYSPNOEA 18485
4 DIARRHOEA 17666
5 DIZZINESS 15992
6 PAIN 14312
7 ASTHENIA 13583
8 HEADACHE 13370
9 FALL 13104
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 314 0.7104
1 PALMOPLANTAR KERATODERMA 303 0.5288
2 IMMUNE-MEDIATED NECROTISING MYOPATHY 251 0.4606
3 IMMUNE-MEDIATED MYOSITIS 420 0.3107
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 271 0.2670
5 MYOPATHY 1866 0.2546
6 HYPERPARATHYROIDISM SECONDARY 582 0.2465
7 NEPHROGENIC ANAEMIA 1033 0.2331
8 ATRIAL TACHYCARDIA 410 0.2284
9 RHABDOMYOLYSIS 7656 0.2174
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]